Navigation Links
Biotech executive books a career flight that's closer to home

Madison, Wis. - Gregg Fergus can tell his fellow travelers a thing or two about commuting.

The Madison native has joined Baird Venture Partners as an executive-in-residence and one of its portfolio companies, Caden Biosciences, as senior vice president of corporate development.

......

Full article >>> Equity, said Fergus would reinforce Baird's focus on the life-science tools market. He expects Fergus to help Baird's healthcare and life science teams evaluate new investment opportunities, and manage its current portfolio of companies. Baird Private Equity has raised and managed $1.8 billion in capital.

Gregg brings operational experience and perspective that will help us in a number o......

Full article >>> re from 800 to 1,000 GPCRs on the human genome. Of those, roughly 400 are thought to be pharmaceutically relevant, but only 40 have been successfully targeted by commercial drugs - representing $50 billion in annual sales - and many of those drugs have side effects.

Caden Biosciences might be able to partner with a big pharma company to pinpoint the remaining intractable targets, and addr......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 02/19/07


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Gala Biotech among companies sold for $3.3 billion
3. Biotech with Madison ties raises $21M in capital
4. Biotech firm uses live heart tissue in drug screens
5. Biotech talent drew venture-funded firm to Madison
6. Biotech firm has strokes, Alzheimers in its sights
7. 42 days until the 2006 Olympics of Biotechnology in Chicago
8. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
9. Biotech leads list of top U.S. companies to work for
10. Biotech flourishes in 2005 while Big Pharma is on the decline
11. Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
Breaking Biology News(10 mins):